Multicancer early detection tests hold great promise for finding cancer early enough to save lives, but there are caveats ...
Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...
Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted ...
In this segment, Dr. Gregory Vidal discusses when biomarker testing is performed during the treatment journey for ER-positive ...
Cologuard and other at-home tests are not intended for and have not been tested in people with Lynch syndrome. Furthermore, ...
For oncologists like me, it would be a different world if we could accurately detect cancer before it metastasised and reassure patients that early intervention saved lives ...
Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer deaths in the U.S., ...
Abbott (NYSE: ABT) today announced a new campaign encouraging people to stop avoiding awkward conversations about colorectal ...
Colorectal cancer is now the No. 1 cause of cancer death in adults under 50 — and a new report shows the trend is getting ...
The Canadian Cancer Society (CCS) has called for a decrease in the age of colorectal cancer screening from the current 50 ...
Age is just a number when it comes to health. Family history screening leads to family finding precancerous polyps. FOX 13’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results